Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Phytochemistry ; 70(7): 871-9, 2009 May.
Article in English | MEDLINE | ID: mdl-19443001

ABSTRACT

This study was aimed at investigating the purification, biological activity, and some structural properties of three serine protease inhibitors isoforms, denoted ApTIA, ApTIB, and ApTIC from Acacia plumosa Lowe seeds. They were purified from the saline extract of the seeds, using Superdex-75 gel filtration and Mono-S ion exchange chromatography. They were further investigated by mass spectrometry, spectroscopic measurements, surface plasmon resonance, and inhibition assays with proteases and phytopathogenic fungi. The molecular mass of each isoform was estimated at ca. 20 kDa. Each contained two polypeptide chains linked by a disulfide bridge, with different isoelectric points that are acidic in nature. The N-terminal sequences of both chains indicated that they were Kunitz-type inhibitors. Circular dichroism (CD) analyses suggested the predominance of both disordered and beta-strands on ApTI isoforms secondary structure, as expected for beta-II proteins. In addition, it was observed that the proteins were very stable, even at either extreme pH values or at high temperature, with denaturation midpoints close to 75 degrees C. The isoinhibitors could delay, up to 10 times, the blood coagulation time in vitro and inhibited action of trypsin (Ki 1.8 nM), alpha-chymotrypsin (Ki 10.3 nM) and kallikrein (Ki 0.58 microM). The binding of ApTIA, ApTIB, and ApTIC to trypsin and alpha-chymotrypsin, was investigated by surface plasmon resonance (SPR), this giving dissociation constants of 0.39, 0.56 and 0.56 nM with trypsin and 7.5, 6.9 and 3.5 nM with alpha-chymotrypsin, respectively. The growth profiles of Aspergillus niger, Thielaviopsis paradoxa and Colletotrichum sp. P10 were also inhibited by each isoforms. These three potent inhibitors from A. plumosa may therefore be of great interest as specific inhibitors to regulate proteolytic processes.


Subject(s)
Acacia/chemistry , Antifungal Agents/isolation & purification , Antifungal Agents/pharmacology , Aprotinin/isolation & purification , Aprotinin/pharmacology , Plants, Medicinal/chemistry , Amino Acid Sequence , Antifungal Agents/chemistry , Aprotinin/chemistry , Aspergillus niger/drug effects , Chymotrypsin/drug effects , Microbial Sensitivity Tests , Sequence Homology, Amino Acid , Trypsin/drug effects
2.
Biotechnol Appl Biochem ; 31(1): 41-53, 2000 02.
Article in English | MEDLINE | ID: mdl-10669401

ABSTRACT

The relationship between protein conformational stability in aqueous solution and the magnitude of lyophilization-induced structural changes was investigated employing alpha- and gamma-chymotrypsin. As a measure of the conformational stability the melting temperature T(m) was determined in distilled water at various pH values. The proteins were then lyophilized from those pH values where the conformational stability was maximum (pH 4.5) and minimum (pH 7.8). Protein secondary structure was quantitatively determined utilizing Fourier-transform infrared spectroscopy employing two regions sensitive to protein structure, the amide-I (1600-1700 cm(-1)) and amide-III (1215-1335 cm(-1)). Lyophilization induced significant structural alterations in both proteins, characterized by a slight decrease in the alpha-helix and a significant increase in the beta-sheet content. However, regardless of the pH from which the proteins were lyophilized, the secondary structures in the solid state were indistinguishable. This result shows that there is no relationship between the conformational stability in aqueous solution and the magnitude of lyophilization-induced structural changes. We also investigated whether lyoprotectants could minimize lyophilization-induced structural changes by increasing protein conformational stability in aqueous solution. After having identified trehalose as being efficient in largely preventing lyophilization-induced structural alterations, we conducted co-lyophilization experiments from various pH values. The results obtained exclude any contribution from increased protein conformational stability caused by the additive in aqueous solution to the beneficial structural preservation upon lyophilization. This can be understood because the dehydration and not the freezing process, as shown in an air-drying experiment, mainly causes protein structural alterations.


Subject(s)
Chymotrypsin/chemistry , Freeze Drying/methods , Chymotrypsin/drug effects , Enzyme Stability , Hydrogen-Ion Concentration , Lactose/chemistry , Lactose/pharmacology , Protein Conformation , Protein Structure, Secondary , Solutions , Spectroscopy, Fourier Transform Infrared , Sugar Alcohols/chemistry , Sugar Alcohols/pharmacology , Trehalose/chemistry , Trehalose/pharmacology , Water
3.
Biochem Mol Biol Int ; 42(6): 1171-7, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9305535

ABSTRACT

Crotamine, a basic, myonecrotic, histamine-releasing neurotoxin, was isolated from Crotalus durissus terrificus venom. Carboxypeptidase A was shown to be activated by crotamine when acting upon N-carbobenzoxyglycil-L-phenylalanine. However the activity of carboxypeptidase B upon the substrate hippuryl-L-arginine was not enhanced by this toxin. Teh basic histamine releasers protamine and compound 48/80 also activated carboxypeptidase A. These three agents activated both alpha-chymotrypsin when acting upon acetyl-L-tyrosine ethyl ester and also five snake venom phospholipase-like myotoxins acting upon egg yolk phosphatidylcholine. These findings suggest that the action of these agents during histamine release may involve the participation of specific intermediary hydrolases which, upon activation, would enhance their cytolytic effects on the sequence of events which lead to granule extrusion and histamine release from mast cells.


Subject(s)
Crotalid Venoms/pharmacology , Histamine Release/drug effects , Phospholipases A/metabolism , Protamines/pharmacology , p-Methoxy-N-methylphenethylamine/pharmacology , Carboxypeptidases/drug effects , Carboxypeptidases/metabolism , Chymotrypsin/drug effects , Chymotrypsin/metabolism , Phospholipases A/drug effects , Snake Venoms/pharmacology
4.
Immunopharmacology ; 32(1-3): 62-6, 1996 May.
Article in English | MEDLINE | ID: mdl-8796268

ABSTRACT

The action of two Bowman-Birk and several plant Kunitz-type inhibitors were studied on trypsin, chymotrypsin, plasma kallikrein and factor XII. The primary structure of some of them was completely defined. The results showed that the Bowman-Birk type inhibitors, although potent inhibitors for trypsin (Ki in the range of 1-2 nM), are not able to inhibit plasma kallikrein. Factor XII (Ki = 1.4 microM) and chymotrypsin (Ki = 5.0 nM) are inhibited by Torresea cearensis trypsin inhibitor (TcTI) but not by Dioclea glabra trypsin inhibitor (DgTI). Both inhibitors reactive site regions are highly homologous, and the amino acid residues in P1 position are the same, Lys and His; major differences are in the charge of the C-terminal portion of the molecules. The studied Kunitz-type inhibitors were all able to inhibit plasma kallikrein (Ki between 4 and 80 nM), with the exception of Schizolobium parahyba chymotrypsin inhibitor (SpCI), that is specific for chymotrypsin. All Kunitz-type inhibitors inactivate chymotrypsin, but with a dissociation constant in the range of 0.1 to 0.6 microM. Factor XIIf is inhibited with Ki in the range of 0.1 microM. Bauhinia bauhinioides trypsin inhibitor (BbTI) did not promote factor XIIf inhibition. The Kunitz-type inhibitors are a highly homologous, sharing 60% identity in the N-terminal portion of the loop containing the reactive site, and 28.6% identity in the C-terminal portion of the same loop.


Subject(s)
Kallikreins/chemistry , Kallikreins/drug effects , Plant Proteins/pharmacology , Serine Proteinase Inhibitors/pharmacology , Trypsin Inhibitor, Bowman-Birk Soybean , Amino Acid Sequence , Animals , Aprotinin/pharmacology , Arachis/enzymology , Chymotrypsin/drug effects , Factor XII/drug effects , Humans , Molecular Sequence Data , Trypsin/drug effects , Trypsin Inhibitors/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL